Effect of carbamazepine and valproate on bone mineral density
- 1 August 1995
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 127 (2) , 256-262
- https://doi.org/10.1016/s0022-3476(95)70304-7
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model.Journal of Clinical Investigation, 1994
- Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometryBone and Mineral, 1992
- Clinical Use of Bone DensitometryNew England Journal of Medicine, 1991
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989
- Lifetime fracture risk: An approach to hip fracture risk assessment based on bone mineral density and ageJournal of Clinical Epidemiology, 1988
- Involutional OsteoporosisNew England Journal of Medicine, 1986
- Does carbamazepine cause disturbances in calcium metabolism in epileptic patients?Acta Neurologica Scandinavica, 1983
- Biochemical evidence for osteomalacia with carbamazepine therapyActa Neurologica Scandinavica, 1980
- Carbamazepine—A double‐blind comparison with phenytoinNeurology, 1977
- Rickets in Children Receiving Anticonvulsant DrugsAmerican Journal of Diseases of Children, 1977